How to Trip Rapid Review

Step 1: Select articles relevant to your search (remember the system is only optimised for single intervention studies)

Step 2: press

Step 3: review the result, and maybe amend the or if you know better! If we're unsure of the overall sentiment of the trial we will display the conclusion under the article title. We then require you to tell us what the correct sentiment is.

3,291 results for

HIPAA

by
...
Latest & greatest
Alerts

Export results

Use check boxes to select individual results below

SmartSearch available

Trip's SmartSearch engine has discovered connected searches & results. Click to show

3241. Security model for picture archiving and communication systems Full Text available with Trip Pro

Security model for picture archiving and communication systems The modern information revolution has facilitated a metamorphosis of health care delivery wrought with the challenges of securing patient sensitive data. To accommodate this reality, Congress passed the Health Insurance Portability and Accountability Act (HIPAA). While final guidance has not fully been resolved at this time, it is up to the health care community to develop and implement comprehensive security strategies founded

2000 Journal of Digital Imaging

3242. Developing policies and procedures for a picture archiving and communication system Full Text available with Trip Pro

. P&P should be written in clear and concise language. Successful P&P development is an ongoing effort. P&P must be periodically reviewed and updated to reflect changes in PACS technology and changes in clinical operations. New P&P must be developed when a deficit is noted. PACS security is a good example of a topic worthy of P&P development, especially in the face of the Health Insurance Portability and Accountability Act (HIPAA) legislation of 1996. What are the provisions for access control

2001 Journal of Digital Imaging

3243. A security architecture for query tools used to access large biomedical databases. Full Text available with Trip Pro

A security architecture for query tools used to access large biomedical databases. Disseminating information from large biomedical databases can be crucial for research. Often this data will be patient-specific, and therefore require that the privacy of the patient be protected. In response to this requirement, HIPAA released regulations for the dissemination of patient data. In many cases, the regulations are so restrictive as to render data useless for many purposes. We propose in this paper

2002 Proceedings of the AMIA Symposium

3244. A proposed key escrow system for secure patient information disclosure in biomedical research databases. Full Text available with Trip Pro

A proposed key escrow system for secure patient information disclosure in biomedical research databases. Access to clinical data is of increasing importance to biomedical research. The pending HIPAA privacy regulations provide specific requirements for the release of protected health information. Under the regulations, biomedical researchers may utilize anonymized data, or adhere to HIPAA requirements regarding protected health information. In order to provide researchers with anonymized data

2002 Proceedings of the AMIA Symposium

3245. A randomized controlled trial of a patient-accessible electronic medical record. Full Text available with Trip Pro

A randomized controlled trial of a patient-accessible electronic medical record. Legal and technologic trends are making medical records more patient-accessible. The Health Insurance Portability and Accountability Act (HIPAA) stipulates that "patients must be able to see and get copies of their records, and request amendments." Medical records are more commonly being stored in electronically, and methods have been developed to share these records with patients in a secure format.1,2 Previous

2003 AMIA ... Annual Symposium proceedings / AMIA Symposium. AMIA Symposium Controlled trial quality: uncertain

3246. Study of ILX651 in Patients With Inoperable Locally Advanced or Metastatic Melanoma

patients with childbearing potential must have a negative pregnancy test within 7 days of study enrollment. Men and women of reproductive potential must use an effective contraceptive method while enrolled in the study. Signed informed consent (includes HIPAA authorization). Exclusion Criteria: Patients with uncontrolled congestive heart failure or angina, patients with a history of myocardial infarction within 2 months of enrollment, or patients with cardiac functional capacity Class III or IV

2003 Clinical Trials

3247. Fludarabine Phosphate, Cyclophosphamide, Tacrolimus, Mycophenolate Mofetil, Total-Body Irradiation, and Donor Bone Marrow Transplant in Treating Patients With High-Risk Hematologic Cancer

: Plan to Share IPD: No Plan Description: Individual patient data is protected by HIPAA at each participant organization. Layout table for additional information Studies a U.S. FDA-regulated Device Product: No Additional relevant MeSH terms: Layout table for MeSH terms Lymphoma Syndrome Leukemia Leukemia, Myeloid Multiple Myeloma Neoplasms, Plasma Cell Leukemia, Myeloid, Acute Lymphoma, Follicular Myelodysplastic Syndromes Preleukemia Lymphoma, Non-Hodgkin Leukemia, Lymphoid Precursor Cell

2002 Clinical Trials

3248. Imatinib Mesylate in Treating Patients With Primary Gastrointestinal Stromal Tumor That Has Been Completely Removed By Surgery

from HIPAA regulations) If patient is a cancer survivor, ALL of the following criteria apply: Patient has undergone potentially curative therapy for all prior malignancies No evidence of any prior malignancies for at least 5 years with no evidence of recurrence (except for effectively treated basal cell or squamous carcinoma of the skin, carcinoma in-situ of the cervix that has been effectively treated by surgery alone, or lobular carcinoma in-situ of the ipsilateral or contralateral breast treated

2002 Clinical Trials

3249. Pain Relief Results After Anterior Cruciate Ligament (ACL) Reconstruction

reactions to the nerve block catehter dressing [ Time Frame: first week after surgery ] Risk of falling [ Time Frame: first week after surgery ] Validation of an 8-item outcome survey in comparison to a 40-item "gold standard" outcome survey [ Time Frame: first week after surgery ] Study staffing costs before and after the implementation of HIPAA [ Time Frame: the 40 months of study recruitment ] Patient-reported general health status, and patient-reported knee function, during the first 12 weeks after

2001 Clinical Trials

3250. Evaluating The Antitumor Activity Of MEDI-522 With Or Without Dacarbazine In Patients With Metastatic Melanoma

provided that therapy ended at least 4 weeks prior to randomization; Patients who had prior surgery are eligible if at least 4 weeks have passed since their surgery; All toxicities related to prior adjuvant therapy must have resolved and all surgical wounds must have healed; Written informed consent and HIPAA authorization obtained from the patient prior to receipt of any study medication or beginning study procedures. Exclusion Patients must have none of the following at the time of randomization

2003 Clinical Trials

3251. Anthrax-rPA: Safety, Tolerability, Immunogenicity

evaluation within the 30 days prior to immunization. Expressed interest and availability to fulfill the study requirements. Signed, informed consents: screening, HIV antibody testing, stored specimen, HIPAA authorization, and protocol-specific consents. Agreement to avoid pregnancy for the 30 days following each vaccination by use of highly effective birth control methods. A highly effective birth control method is defined as one which results in a failure rate less than 1% per year when used

2003 Clinical Trials

3252. MEDI-522 in the Treatment of Patients With Metastatic Androgen-Independent Prostate Cancer

provided at least 4 weeks have passed since last treatment prior to randomization. Written informed consent and HIPAA authorization (USA sites only) obtained from the patient prior to receipt of any study medication or beginning study procedures. Exclusion Criteria: Prior chemotherapy for metastatic prostate cancer (prior adjuvant chemotherapy is allowed provided it is non-taxane based and at least 6 months have passed since last treatment). Prior treatment with other investigational agents within 4

2003 Clinical Trials

3253. Paclitaxel in Treating Patients With Ovarian Stromal Cancer

an effective means of birth control Patients who have met the pre-entry requirements as specified Patients must have signed an approved informed consent and Health Insurance Portability and Accountability Act (HIPAA) authorization Exclusion Criteria: Patients with GOG performance grade of 3 or 4 Patients with a prior invasive malignancy (except non-melanoma skin cancer) who have had any evidence of disease within the last 5 years or whose prior malignancy treatment contraindicates the current protocol

2000 Clinical Trials

3254. The Copernican era of healthcare terminology: a re-centering of health information systems. Full Text available with Trip Pro

, and efficient practice patterns. The fabled linkage of knowledge sources at the time and place of care requires the conceptual intermediary of common terminology. A brief history overviewing the evolution of health classifications will provide the foundation for considering present and evolving health terminology developments. Their roles in health information systems will be characterized. Discussion will focus on the likely influences of the HIPAA legislation nationally and the new ISO Healthcare

1998 Proceedings of the AMIA Symposium

3255. Clinical data exchange standards and vocabularies for messages. Full Text available with Trip Pro

Clinical data exchange standards and vocabularies for messages. Motivation for the creation of electronic data interchange (message) standards is discussed. The ISO Open Systems Interface model is described. Clinical information models, message syntax and structure, and the need for a standardized coded vocabulary are explained. The HIPAA legislation and subsequent HHS transaction recommendations are reviewed. The history and mission statements of six of the most popular message development

1998 Proceedings of the AMIA Symposium

3256. Development of CPR security using impact analysis. Full Text available with Trip Pro

Development of CPR security using impact analysis. The HIPAA regulations will require that institutions ensure the prevention of unauthorized access to electronically stored or transmitted patient records. This paper discusses a process for analyzing the impact of security mechanisms on users of computerized patient records through "behind the scenes" electronic access audits. In this way, those impacts can be assessed and refined to an acceptable standard prior to implementation. Through

2000 Proceedings of the AMIA Symposium

3257. Information Needs of Residents During Inpatient and Outpatient Rotations: Identifying Effective Personal Digital Assistant Applications Full Text available with Trip Pro

source of information, a source that was viewed as being too easy to lose or break. Three broad patterns emerged. First, residents in all seven of our surveyed practices use PDAs and most surveyed residents use them on a daily basis; we conclude that PDAs are being widely used across the spectrum of generalist to specialty practices, regardless of whether a residency program specifically encourages PDA usage. Second, security and HIPAA compliance issues need to be addressed, in part by resident

2003 AMIA Annual Symposium Proceedings

3258. Patient Online at Dartmouth-Hitchcock – Interactive Patient Care Web Site Full Text available with Trip Pro

Patient Online at Dartmouth-Hitchcock – Interactive Patient Care Web Site This poster presentation will demonstrate the value to practices of providing online interactive communication tools to their patients by presenting Dartmouth-Hitchcock's successful implementation of "Patient Online". This tool extends our clinical and administrative functions directly to patients using a personal web site product that supports HIPAA compliant clinical communication, patient appointment scheduling

2003 AMIA Annual Symposium Proceedings

3259. Secure De-identification and Re-identification Full Text available with Trip Pro

Secure De-identification and Re-identification Today's healthcare organizations have both an ethical and legal responsibility for protecting patient privacy. However, the HIPAA privacy rule allows for the release of de-identified patient data for certain purposes. Secure encryption technology can be used to encrypt patient identified data so only the owners of the original data can re-identify the patient. It further allows consistent de-identification over episodic collection events.

2003 AMIA Annual Symposium Proceedings

3260. Navigating the Road to Implementation of the Health Insurance Portability and Accountability Act Full Text available with Trip Pro

Navigating the Road to Implementation of the Health Insurance Portability and Accountability Act The Health Insurance Portability and Accountability Act of 1996 (HIPAA) has a profound impact on safety net providers. To help agencies afford expert consultation and provide the opportunity for collaboration, a regional health foundation has created the first model in the nation to bring together safety net providers to work toward implementation of the HIPAA.

2003 American Journal of Public Health

To help you find the content you need quickly, you can filter your results via the categories on the right-hand side >>>>